Predictive models for maximum recommended therapeutic dose of antiretroviral drugs
DOI10.1155/2012/469769zbMATH Open1234.92025OpenAlexW2045925231WikidataQ42589175 ScholiaQ42589175MaRDI QIDQ764174FDOQ764174
Authors: Michael Lee Branham, Edward A. Ross, Thirumala Govender 
Publication date: 13 March 2012
Published in: Computational \& Mathematical Methods in Medicine (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1155/2012/469769
Recommendations
- QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors
- Aug-MIA-QSAR based strategy in bioactivity prediction of a series of flavonoid derivatives as HIV-1 inhibitors
- Prediction of IC\(_50\) values of 2-benzyloxybenzamide derivatives using multiple linear regression and artificial neural network methods
- Application to QSAR studies of 2-furylethylene derivatives
- Hierarchical Bayes model for predicting effectiveness of HIV combination therapies
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Biochemistry, molecular biology (92C40) Neural networks for/in biological studies, artificial life and related topics (92B20)
Cites Work
Cited In (6)
- Title not available (Why is that?)
- Models for prediction of anti-HIV-1 activity of 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4\((3H)\)-ones using random forest, decision tree and moving average analysis
- The application of conformal prediction to the drug discovery process
- \textit{In vitro} transcriptomic prediction of hepatotoxicity for early drug discovery
- Accurate modeling of complex antitoxin effect of Quercetin based on neural networks
- Predicting inhibition constants of antimalarial drug compounds using support vector regression
This page was built for publication: Predictive models for maximum recommended therapeutic dose of antiretroviral drugs
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q764174)
